- Home
- IE vs HRMY Comparison
IE vs HRMY Comparison
Compare IE & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IE | HRMY |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IE | HRMY |
|---|---|---|
| Price | $11.51 | $32.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $18.17 | ★ $44.11 |
| AVG Volume (30 Days) | ★ 1.7M | 731.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.97 |
| EPS | N/A | ★ 0.55 |
| Revenue | $3,244,000.00 | ★ $868,453,000.00 |
| Revenue This Year | $44.79 | $19.75 |
| Revenue Next Year | $16.22 | $12.88 |
| P/E Ratio | ★ N/A | $59.93 |
| Revenue Growth | 11.82 | ★ 21.51 |
| 52 Week Low | $7.72 | $25.52 |
| 52 Week High | $21.55 | $40.87 |
Technical Indicators
Market Signals| Indicator | IE | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 57.60 |
| Support Level | $8.53 | $31.61 |
| Resistance Level | $15.70 | $33.11 |
| Average True Range (ATR) | 0.87 | 0.90 |
| MACD | -0.03 | 0.17 |
| Stochastic Oscillator | 2.57 | 74.08 |
Price Performance
Historical ComparisonAbout IE Ivanhoe Electric Inc.
Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.